[1]Guideline for the pharmacological treatment of hypertension in adults [Internet]. Geneva: World Health Organization; 2021. PMID: 34495610.
[2]Verdecchia P, Reboldi G, Angeli F. The 2020 International Society of Hypertension global hypertension practice guidelines - key messages and clinical considerations. Eur J Intern Med. 2020 Dec;82:1-6.
[3]孙宁玲, 霍勇, 王继光, 等. 难治性高血压诊断治疗中国专家共识[J]. 中国医学前沿杂志, 2013, 5(6): 5-12.
[4]王文, 刘明波, 隋辉, 等. 中国心血管病的流行状况与防治对策[J]. 中国心血管杂志, 2012, 17(5): 321-323.
[5]中国高血压防治指南修订委员会. 中国高血压防治指南 2010[J]. 中国医学前沿杂志, 2011, 3(5): 42-93.
[6]Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension Practice Guidelines. Hypertension. 2020;75(6):1334-1357.
[7]Rossi GP, Bisogni V, Rossitto G, et al. Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension. High Blood Press Cardiovasc Prev. 2020;27(6):547-560.
[8]全国高血压日 关注年轻的“老年病”患者http://www.news.cn/politics/2022-10/07/c_1129053917.htm